Decrease in CD3-negative-CD8dim+ and Vδ2/Vγ9 TcR + peripheral blood lymphocyte counts, low perforin expression and the impairment of natural killer cell activity is associated with chronic hepatitis C virus infection

Journal of Hepatology

Volumn 37, Issue 4, 2002, Pages 514-522

  Pár, Gabriella ^a   Rukavina, Daniel ^b   Podack, Eckhard R ^c   Horányi, Margit ^d   Szekeres Barthó, Júlia ^a   Hegedüs, Géza ^e   Paál, Mária ^f   Szereday, László ^a   Mózsik, Gyula ^a   Pár, Alajos ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF RIJEKA   (Croatia)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d National Institute of Haematology and Immunology Budapest   (Hungary)

^e Baranya County Hospital   (Hungary)

^f Blood Transfusion Centre   (Hungary)

Author keywords

CD3 negative CD8+ lymphocytes; Gamma delta T cells; Hepatitis C virus; Interferon; Natural killer cytotoxicity; Perforin

Indexed keywords

ALANINE AMINOTRANSFERASE; CD3 ANTIGEN; CD8 ANTIGEN; PERFORIN; RECOMBINANT ALPHA2B INTERFERON; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; ALPHA2B INTERFERON; ANTIVIRUS AGENT; LYMPHOCYTE ANTIGEN RECEPTOR; MEMBRANE PROTEIN; PORE FORMING CYTOTOXIC PROTEIN;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; FLOW CYTOMETRY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LYMPHOCYTE COUNT; MALE; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; CHEMISTRY; CLINICAL TRIAL; GENE REARRANGEMENT; IMMUNOLOGY; IMMUNOPHENOTYPING; MIDDLE AGED; VIROLOGY;

ADULT; AGED; ANTIGENS, CD3; ANTIGENS, CD8; ANTIVIRAL AGENTS; FEMALE; FLOW CYTOMETRY; GENE REARRANGEMENT, DELTA-CHAIN T-CELL ANTIGEN RECEPTOR; GENE REARRANGEMENT, GAMMA-CHAIN T-CELL ANTIGEN RECEPTOR; HEPATITIS C, CHRONIC; HUMANS; IMMUNOPHENOTYPING; INTERFERON ALFA-2B; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PORE FORMING CYTOTOXIC PROTEINS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA;

EID: 0036783791     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(02)00218-0     Document Type: Article

References (47)

1. Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology 1991;14:969-974.
2. Farci P, Shimoda A, Coiana A, Diaz G, Peddis G, Melpolder JC, et al. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 2000;288(5464):339-344.
3. Gruener NH, Lechner F, Jung MC, Diepolder H, Gerlach T, Lauer G, et al. Sustained dysfunction of antiviral CD8 + T lymphocytes after infection with hepatitis C virus. J Virol 2001;75:5550-5558.
4. Gerlach JT, Diepolder HM, Jung MC, Gruener NH, Schraut WW, Zachoval R, et al. Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. Gastroenterology 1999;117(4):933-941.
5. Schirren CA, Jung MC, Gerlach JT, Worzfeld T, Baretton G, Mamin M, et al. Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gamma. Hepatology 2000;32:597-603.
6. Eckels DD, Wang H, Bian TH, Tabatabai N, Gill JC. Immunobiology of hepatitis C virus (HCV) infection: the role of CD4 T cells in HCV infection. Immunol Rev 2000;174:90-97.
7. Yonekura K, Ichida T, Sato K, Yamagiwa S, Uchida M, Sugahara S, et al. Liver-infiltrating CD56 positive T lymphocytes in hepatitis C virus infection. Liver 2000;20:357-365.
8. Fiore G, Angarano I, Caccetta L, Serrone M, Jirillo E, Schiraaldi O, et al. In-situ immunophenotyping study of hepatic infiltrating cytotoxic cells in chronic active hepatitis C. Eur J Gastroent Hepatol 1997;9:491-496.
9. Gonzales-Peralta RP, Davis GL, Lau JYN. Pathogenetic mechanisms of hepatocellular damage in chronic hepatitis C virus infection. J Hepatol 1994;21:255-259.
10. Valiante NM, D'Andrea A, Crotta S, Lechner F, Klenerman P, Nuti S, et al. Life, activation and death of intrahepatic lymphocytes in chronic hepatitis C. Immunol Rev 2000;174:77-89.
11. Mehal WZ, Azzaroli F, Crispe N. Immunology of the healthy liver: old questions and new insights. Gastroenterology 2001;120:250-260.
12. Pár A, Paál M, Gógl Á, Gervain J, Szekeres-Bartho J, Sipos J, et al. Chronic hepatitis C: clinical and immunological features and the effect of interferon treatment. Int J Immunother 1995;11:115-127.
13. Corado J, Toro F, Rivera H, Bianco NE, Deibis L, De Sanctis JB. Impairment of natural killer (NK) cytotoxic activity in hepatitis C virus (HCV) infection. Clin Exp Immunol 1997;109:451-457.
14. Castiglione G, Guglietta A, Lirussi F, Natural killer (NK) cell cytotoxicity in chronic HCV infection. Relationship with clinical and virological features and response to interferon (IFN). J Hepatol 2001;34(Suppl 1):131.
15. Gabrielli A, Sambo P, Zhang ZX, Candela M, Savoldi S, Manzin A, et al. Humoral immune response and natural killer activity in patients with mixed cryoglobulinemia. Clin Exp Immunol 1995;13(Suppl 13):S95-S99.
16. Bonavita MS, Franco A, Paroli M, Santilio I, Benvenuto R, De Petrillo G, et al. Normalization of depressed natural killer activity after interferon-alpha therapy is associated with a low frequency of relapse in patients with chronic hepatitis C. Int J Tissue React 1993;15:11-16.
17. Griffiths GM, Mueller C. Expression of perforin and granzymes in vivo: potential diagnostic markers for activated cytotoxic cells. Immunol Today 1991;12:415-419.
18. Podack ER, Hengartner H, Lichtenheld MG. A central role of perforin in cytolysis? Annu Rev Immunol 1991;9:129-157.
19. Lichtenheld MG, Olsen KJ, Lu P, Lowrey DM, Hameed A, Hengartner H, et al. Structure and function of human perforin. Nature 1988;335:448-451.
20. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-435.
21. Garson JA, Tedder RS, Briggs M, Tuke P, Glazebrook JA, Tute A, et al. Detection of hepatitis C viral sequences in blood donation by 'nested' polymerase chain reaction and prediction of infectivity. Lancet 1990;1:1419-1422.
22. Grimm E, Bonavida B. Mechanism of cell mediated cytotoxicity at the single cell level. Estimation of cytotoxic T lymphocyte frequency and relative lytic efficiency. J Immunol 1979;123:2861-2869.
23. Barakonyi A, Kovacs KT, Miko E, Szereday L, Varga P, Szekeres-Bartho J. Recognition of nonclassical HLA Class I antigens by γδ T cells during pregnancy. J Immunol 2002;168:2683-2688.
24. Slezak SE, Horan PK. Cell-mediated cytotoxicity. A highly sensitive and informative flow cytometric assay. J Immunol Methods 1989;117:205-214.
25. Mansour I, Jarraya MA, Gane P, Roquin H, Rouger P, Doinel C. Triple labeling with two-colour immunofluorescence using one light source: a useful approach for analysis of cells positive for one label and negative for the other two. Cytometry 1990;11:636-641.
26. Rutella S, Rumi C, Lucia MB, Etuk B, Cauda R, Leone G. Flow cytometric detection of perforin in normal human lymphocyte subpopulations defined by expression of activation/differentiation antigens. Immunol Lett 1998;60:51-55.
27. Robertson J, Ritz J. Biology and clinical relevance of human natural killer cells. Blood 1990;76:2421-2438.
28. Zignego AL, Ferri C, Giannini C, La Civita L, Careccia G, Longombardo G, et al. Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role. Arch Virol 1997;142:545-555.
29. Zignego A, Brechot C. Extrahepatic manifestations of HCV infection: facts and controversies. J Hepatol 1999;31:369-376.
30. Rukavina D, Laskarin G, Rubesa G, Strbo N, Bedenicki I, Manestar D, et al. Age-related decline of perforin expression in human cytotoxic T lymphocytes and natural killer cells. Blood 1998;92:2410-2420.
31. Parrado A, Casares S, Rodriquez-Fernandez JM. Natural killer cytotoxicity and lymphocyte subpopulations in patients with acute leukemia. Leukemia Res 1994;18:191-197.
32. Lanier LL. Unusual lymphocytes - γ/δT cells and NK cells. The Immunologist 1995;3:182-184.
33. Wallace M, Malkovsky M, Carding SR. Gamma/delta T lymphocytes in viral infections. Leukocyte Biol 1995;58:277-283.
34. Triebel F, Hercend T. Subpopulations of human peripheral T gamma delta lymphocytes. Immunol Today 1989;10:186-188.
35. Fisch P, Meuer E, Pende D, Rothenfusser S, Viale O, Kock S, et al. Control of B cell lymphoma recognition via natural killer inhibitory receptors implies a role for human Vγ9/Vδ2 T cells in tumor immunity. Eur J Immunol 1997;27:3368-3379.
36. Bukowski JF, Morita CT, Brenner MB. Recognition and destruction of virus-infected cells by human γδ CTL. J Immunol 1994;153:5133-5140.
37. Tseng CT, Miskovsky E, Houghton M, Klimpel GR. Characterization of liver T-cell receptor gammadelta T cells obtained from individuals chronically infected with hepatitis C virus (HCV): evidence for these T cells playing a role in the liver pathology associated with HCV infections. Hepatology 2001;33:1312-1320.
38. Kakumu S, Ishikawa T, Okumura A, Yoshioka K. Interleukin 2 and γ/δT cell receptors in peripheral blood of patients with chronic hepatitis C virus infection. Hepatol Res 1997;7:83-93.
39. Agrati C, D'Offizi G, Narciso P, Abrignani S, Ippolito G, Colizzi V, et al. V deltaI T lymphocytes expressing a Th1 phenotype are the major gammadelta T cell subset infiltrating the liver of HCV-infected persons. Mol Med 2001;7:11-19.
40. Ando K, Hiroishi K, Kaneko T, Moriyama T, Muto Y, Kayagaki N, et al. Perforin Fas/Fas ligand and TNF-alpha pathways as specific bystander killing mechanism of hepatitis C virus specific human CTL. J Immunol 1997;158:5283-5291.
41. Kaser A, Enrich B, Ludwiczek O, Vogel W, Tilg H. Interferon-alpha (IFN-α) enhances cytotoxicity in healthy volunteers and chronic hepatitis C infection mainly by the perforin pathway. Clin Exp Immunol 1999;118:71-77.
42. Balian A, Naveau S, Zou W, Durand-Gasselin I, Bouchet L, Foussat A, et al. Pre-treatment expression of the perforin gene by circulating CD8(+) T lymphocytes predicts biochemical response to interferon-alpha in patients with chronic hepatitis C. Eur Cytokine Netw 2000;11:177-184.
43. Tseng CT, Klimpel GR. Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J Exp Med 2002;195(1):43-49.
44. Crotta S, Stilla A, Wack A, D'Andrea A, Nuti S, D'Oro U, et al. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J Exp Med 2002;195:35-42.
45. Doherty DG, Norris S, Madrigal-Estebas L, McEntee G, Traynor O, Hegarty JE, et al. The human liver contains multiple populations of NK cells, T cells, and CD3 + CD56 + natural T cells with distinct cytotoxic activities and Th1, Th2 and Th0 cytokine secretion patterns. J Immunol 1999;163:2314-2321.
46. Klenerman P, Lechner F, Kantzanou M, Ciurea A, Hengartner H, Zinkernagel R. Viral escape and the failure of cellular immune responses. Science 2000;289:2003.
47. Planz O, Ehl S, Furrer E, Horvath E, Brundler MA, Hengartner H, et al. A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers. Proc Natl Acad Sci USA 1997;94(13):6874-6879.